跳至主要内容
临床试验/EUCTR2019-000971-17-BE
EUCTR2019-000971-17-BE进行中(未招募)1 期

Double trigger and ovum retrieval vs. conventional antagonist ovarian stimulation protocol in poor prognosis women undergoing IVF/ICSI: A pilot study - DUOPICK

Z Brussel0 个研究点目标入组 46 人开始时间: 2019年5月14日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • - Age 25-40 years
  • - BMI = 35 and = 19
  • -Antimüllerian hormone (AMH) level of =1.5 ng/mL or antral follicular count of =6 follicles or =5 oocytes retrieved in a previous cycle following standard conventional ovarian stimulation.
  • - =9 follicles >11 mm on the day of first trigger
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 46
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • history of more than three consecutive previous unsuccessful IVF/ICSI cycles, BMI >35 or <19, PCOS according to the Rotterdam criteria, ovarian stimulation for for pre-implantation genetic testing (PGT-A/M), medical/social freezing, in vitro maturation (IVM), use of oral contraceptives >3 months before start of the treatment, testicular sperm extraction; history of untreated autoimmune, endocrine or metabolic disorders, ovarian cystectomy or oophorectomy.

研究者

发起方
Z Brussel

相似试验